Nuevolution A/S Appoints Professor Mark C. Genovese as Advisor
News Nov 21, 2015
Nuevolution has announced that Dr. Mark Genovese has joined as Scientific Advisor. Mark brings a vast knowledge and expertise within the field of inflammatory diseases to Nuevolution as well as a profound understanding of pre-clinical and clinical research, supporting the commercial value of Nuevolution’s program pipeline.
Dr. Genovese serves as a Professor of Medicine and is Co-Chief of the Division of Immunology and Rheumatology at Stanford University Medical Center. He established a clinical research program at Stanford University that is focused on bench-to-bedside translational medicine in autoimmune diseases and has designed and participated in many trials investigating novel therapies and therapeutic strategies for the treatment of autoimmune disease and arthritis.
“We are happy to have initiated our collaboration with Mark, who is a leader in the field of clinical immunology, and that he has accepted to join our Advisory Panel, said Thomas Franch, CSO of Nuevolution. “We are certain that Mark’s expertise will help us to accelerate our immunology projects further to meet our ambitions of providing novel treatment options for inflammatory diseases”.
Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the BodyNews
Human Malaria Parasites Grown for the First Time in Dormant FormNews
One of the biggest obstacles to eradicating malaria is a dormant form of the parasite which is resistant to most antimalarial drugs and can reawaken years later, causing disease relapse. Researchers have shown they can grow the dormant parasite in engineered human liver tissue for several weeks, allowing them to closely study how the parasite becomes dormant, what vulnerabilities it may have, and how it springs back to life.READ MORE
Bacteria Produce More Substances Than Genetics PredictedNews
Tandem mass spectrometry has revealed that Streptomyces chartreusis, an antibiotic-producing bacterium, releases more metabolites into the surrounding medium than scientists assumed based on the analysis of the genome. They might include molecules that are of interest as potential pharmaceutical agents.READ MORE